209 related articles for article (PubMed ID: 18751426)
41. Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study.
Kobayashi H; Tanaka Y; Yagi J; Osaka Y; Nakazawa H; Uchiyama T; Minato N; Toma H
Cancer Immunol Immunother; 2007 Apr; 56(4):469-76. PubMed ID: 16850345
[TBL] [Abstract][Full Text] [Related]
42. Progressive divergent shifts in natural and induced T-regulatory cells signify the transition from undifferentiated to definitive connective tissue disease.
Szodoray P; Nakken B; Barath S; Gaal J; Aleksza M; Zeher M; Sipka S; Szilagyi A; Zold E; Szegedi G; Bodolay E
Int Immunol; 2008 Aug; 20(8):971-9. PubMed ID: 18550583
[TBL] [Abstract][Full Text] [Related]
43. B7-1 and B7-2 differentially control peripheral homeostasis of CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Jan; 20(3):171-9. PubMed ID: 18848987
[TBL] [Abstract][Full Text] [Related]
44. Tumor-specific regulatory T cells in cancer patients.
Piersma SJ; Welters MJ; van der Burg SH
Hum Immunol; 2008; 69(4-5):241-9. PubMed ID: 18486758
[TBL] [Abstract][Full Text] [Related]
45. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis.
Olivito B; Simonini G; Ciullini S; Moriondo M; Betti L; Gambineri E; Cantarini L; De Martino M; Azzari C; Cimaz R
J Rheumatol; 2009 Sep; 36(9):2017-24. PubMed ID: 19648312
[TBL] [Abstract][Full Text] [Related]
46. Relationship of frequency of CD4+CD25+Foxp3+ regulatory T cells with disease progression in antiretroviral-naive HIV-1 infected Chinese.
Zhang Z; Jiang Y; Zhang M; Shi W; Liu J; Han X; Wang Y; Jin X; Shang H
Jpn J Infect Dis; 2008 Sep; 61(5):391-2. PubMed ID: 18806350
[TBL] [Abstract][Full Text] [Related]
47. [Analysis of CD4+CD25+Foxp3+ regulatory T cells in patients of haemorrhagic fever with renal syndrome].
Nie ST; Li Q; Wang HY
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):817-9. PubMed ID: 19595120
[TBL] [Abstract][Full Text] [Related]
48. Regulatory T cells and asthma.
Robinson DS
Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
[TBL] [Abstract][Full Text] [Related]
49. The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.
Li JF; Chu YW; Wang GM; Zhu TY; Rong RM; Hou J; Xu M
BJU Int; 2009 Feb; 103(3):399-405. PubMed ID: 19021626
[TBL] [Abstract][Full Text] [Related]
50. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
[TBL] [Abstract][Full Text] [Related]
51. Deficiency of regulatory T cells in children with autoimmune neutropenia.
Nakamura K; Miki M; Mizoguchi Y; Karakawa S; Sato T; Kobayashi M
Br J Haematol; 2009 Jun; 145(5):642-7. PubMed ID: 19344427
[TBL] [Abstract][Full Text] [Related]
52. Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study.
Schuetz F; Ehlert K; Ge Y; Schneeweiss A; Rom J; Inzkirweli N; Sohn C; Schirrmacher V; Beckhove P
Cancer Immunol Immunother; 2009 Jun; 58(6):887-900. PubMed ID: 18998129
[TBL] [Abstract][Full Text] [Related]
53. [Alteration and biological significance of peripheral dendritic cells in patients with chronic idiopathic thrombocytopenic purpura].
Ling Y; Cao XS; Yu ZQ; Qiu GQ; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):187-91. PubMed ID: 18788620
[TBL] [Abstract][Full Text] [Related]
54. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship.
Mahnke K; Johnson TS; Ring S; Enk AH
J Dermatol Sci; 2007 Jun; 46(3):159-67. PubMed ID: 17428639
[TBL] [Abstract][Full Text] [Related]
55. Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes.
Kondo H; Hazama S; Kawaoka T; Yoshino S; Yoshida S; Tokuno K; Takashima M; Ueno T; Hinoda Y; Oka M
Anticancer Res; 2008; 28(1B):379-87. PubMed ID: 18383873
[TBL] [Abstract][Full Text] [Related]
56. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
57. Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients.
Lissoni P; Brivio F; Fumagalli L; Messina G; Meregalli S; Porro G; Rovelli F; Vigorè L; Tisi E; D'Amico G
Anticancer Res; 2009 May; 29(5):1847-52. PubMed ID: 19443415
[TBL] [Abstract][Full Text] [Related]
58. [Relationship of levels of CD4(+)CD25(+) regulatory T cells and expression of Foxp3 mRNA in peripheral blood with serum immunoglobulin E level in children with bronchiolitis].
Zhu YF; Zhu JY; Li WW; Lan CF; Fang J; Lin HL
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):349-53. PubMed ID: 19470254
[TBL] [Abstract][Full Text] [Related]
59. Decreased number of FoxP3+ regulatory T cells in preeclampsia.
Toldi G; Svec P; Vásárhelyi B; Mészáros G; Rigó J; Tulassay T; Treszl A
Acta Obstet Gynecol Scand; 2008; 87(11):1229-33. PubMed ID: 19016357
[TBL] [Abstract][Full Text] [Related]
60. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
Wang LH; Lin YH; Yang J; Guo W
Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
